2017•PubMedRequires access
Loss of CD45 expression at relapse of acute myeloid leukemia.
Katsuya Yamamoto, Kimikazu Yakushijin, Keiji Kurata, Yu Mizutani, Yumiko Inui, Kiyoaki Uryu, Shinichiro Kawamoto, T Sugimoto, Hiroshi Matsuoka, Hironobu Minami
Open publisher page 0 citations
Abstract
A 49-year-old female was initially diagnosed with acute myeloid leukemia (AML) M4 with a CD45＋CD13＋CD33＋CD34-HLA-DR＋ immunophenotype. She underwent allogeneic bone marrow transplantation, but the disease recurred. The bone marrow was infiltrated with 87.0% blasts negative for myeloperoxidase (MPO) staining. Immunophenotyping by flow cytometry identified the presence of a CD45-negative blast population. These blasts exhibited a CD13＋CD33＋CD19-CD10-CD34-HLA-DR- immunophenotype. The lack of CD45 expression is often observed in B-cell acute lymphoblastic leukemia, whereas CD45-negative AML is extremely rare; only one older male with AML-M0 has been reported. In the present case, the CD45-negative blasts had an MPO-CD13＋CD33＋ phenotype, which is similar to AML-M0.